Press "Enter" to skip to content

Tag: COVID-19

Call for the creation of a national registry for long COVID

The second Canadian Symposium on Long COVID came to a close in Edmonton on Friday, with an urgent call for the establishment of a national registry for the condition.

The event, organized by Long Covid Web, a network dedicated to research and support for people suffering from post COVID-19 condition, in collaboration with the University of Alberta, University of Calgary, and Alberta Health Services, brought together researchers, clinicians and patients to discuss the challenges associated with the condition.

The speakers’ testimonies highlighted the devastating impact of long COVID on patients’ daily lives.

Comments closed

Ottawa’s wastewater surveillance program extended for another year

Two months after the Ontario government pulled the plug on wastewater surveillance, Ottawa health and research institutions have teamed up to extend the program in the city for a least another year.

Calling it an innovative solution that allowed for better monitoring of COVID-19 in the community, CHEO, the CHEO Research Institute, the University of Ottawa and Ottawa Public Health announced an extension of wastewater surveillance on Friday.

In addition to monitoring COVID-19 levels in wastewater, the program monitors levels of influenza, RSV and mpox in Ottawa. The program has been extended until September 2025.

Comments closed

uOttawa, CHEO and OPH extend monitoring of viruses in wastewater to 2025

Our research group is truly grateful for the overwhelming support we’ve received from the community over the past few months through emails, letters, and phone calls advocating for the continuation of our wastewater monitoring system.

We’ve gained invaluable insights into how this information is essential for community members facing health challenges, and we are thrilled to continue providing this vital service. A heartfelt thank you to OPH, CHEO, and CHEO-RI for their unwavering support.

— Dr. Robert Delatolla
Comments closed

No flu or COVID-19 vaccines for medical clinics as Alberta’s fall immunization launch nears

Family doctors and nurse practitioners have been told they will not be receiving deliveries of flu or COVID-19 vaccines in time for the fall immunization program launch later this month. And it is unclear if they will get any at all.

In addition to AHS public health clinics and pharmacies, community medical clinics can administer publicly funded vaccines, including those that protect against COVID and influenza.

But shipments of vaccines — to these clinics — have stopped, jeopardizing their participation in the fall immunization campaign.

Comments closed

COVID-19 boosters start rolling out to some Canadians. Who can get them?

Updated COVID-19 vaccines are starting to roll out to some high-risk Canadians, but others will have to wait a little while longer before these new shots are offered to them.

Last month, Health Canada approved Pfizer and Moderna’s latest COVID-19 vaccines targeting the most recent variants of the virus.

Both shots are approved for everyone aged six months and older.

The new mRNA vaccines from both pharmaceutical companies target the KP.2 subvariant of Omicron that was dominating COVID-19 spread earlier this year.

Comments closed

COVID-19 prevalence high and rising across most of province as BCCDC revamps reporting dashboards

The prevalence of SARS-CoV-2 – the virus that causes COVID-19 – in B.C. wastewater is high and rising across most regions, according to the latest data from the B.C. Centre for Disease Control.

The BCCDC released its first weekly data update of the 2024-25 respiratory illness season Thursday, and took the opportunity to dramatically revise the information it presents and the way it is presented.

Gone is the previous year’s “COVID-19 Situation Report” dashboard, replaced with a new dashboard titled “Viral Respiratory Outcomes.”

While the situation report included specific numbers for newly confirmed infections, hospital admissions, critical care admissions and deaths within 30 days of a positive COVID test, the new dashboard reports the latter three numbers as a rate per million residents.

Comments closed

People in Sudbury say free COVID-19 rapid test kits are hard to come by

Along with an increase in colds and the flu across northern Ontario this fall; pharmacies are seeing a bump in people searching, unsuccessfully, for rapid antigen COVID-19 tests to take at home.

In Sudbury, Ont., Lucio Fabris was one of them.

He recently went on the hunt for a test for his wife who had been exposed to COVID-19.

They were expecting a grandchild and they didn’t want to spread the virus to vulnerable family members.

Comments closed

For Canadians seeking a non-mRNA COVID vaccine, lack of Novavax shot is ‘unfair,’ advocates say

The federal government’s decision to not provide Novavax’s COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say, as some Canadians look to the U.S. to get the shot.

The Public Health Agency of Canada said it won’t provide the protein-based vaccine called Nuvaxovid because the manufacturer required a minimum order that far exceeds last year’s uptake of the vaccine.

The health agency said 125,000 Nuvaxovid doses were ordered in 2023, but only 5,529 were administered. This fall, it will only supply provinces and territories with the reformulated Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines.

But some Canadians who say they are immunocompromised and have had adverse reactions to the mRNA vaccines are calling the decision unfair.

Comments closed

Canadian government not ordering Novavax’s protein-based COVID-19 vaccine this year

TORONTO – The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing low demand.

It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.

The agency says a very small portion of the doses ordered in 2023 were used and that its decision reflects efforts to limit vaccine wastage.

It is distributing two mRNA vaccines — made by Pfizer-BioNTech and Moderna — that are approved for adults and children six months and older.

Comments closed

Rep. Ilhan Omar to Introduce Major Long Covid Bill

On Friday, Minnesota Rep. Ilhan Omar (D-Minn.) will introduce a potentially groundbreaking piece of federal legislation in the House of Representatives—one allocating $10 billion in funding to fight Long Covid, the increasingly widespread, chronic condition that follows many Covid infections. The Long Covid Research Moonshot Act is a companion bill to one that Sen. Bernie Sanders (I-Vt.) introduced in the Senate in August.

“Long Covid is a silent health crisis impacting over twenty-three million Americans, including one million children,” Omar said in a statement to Mother Jones. (Rep. Ayanna Pressley, D-Mass., is the co-lead on the legislation.) “I’m proud to lead this effort in the House to recognize Long Covid as the public health emergency that it is and invest in countering the effects of this terrible disease.”

Long Covid symptoms often include debilitating fatigue, and many people found to have it have also been diagnosed with conditions like myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome. ME/CFS, which is characterized by post-exertional malaise, is known to be associated with other infectious diseases—the CDC states that about 1 in 10 people infected by the Epstein-Barr virus (which 95 percent of adults get) experience ME/CFS-like symptoms. And research shows that repeated Covid infections increase people’s risk of developing Long Covid.

Comments closed

The N.W.T. now has a virus ‘dashboard’ so you can see COVID-19, flu and RSV trends

Data collected by wastewater monitoring in six N.W.T. communities is being put to a new use: an online dashboard that tracks how much COVID-19, flu and RSV are in those communities.

The N.W.T. government announced the new dashboard Wednesday in a news release. It covers Yellowknife, Behchokǫ̀, Fort Smith, Fort Simpson, Hay River and Norman Wells.

The dashboard is updated once a week on Tuesdays. For the most recent reporting period, as of Wednesday, it didn’t have data for Hay River but showed COVID-19 was still being detected to a high or moderate level in all the other communities. No detection was noted for flu or RSV.

Comments closed

Want To Prevent Long Covid? Should You Take Metformin Or Paxlovid?

Previously, I wrote about Paxlovid being underprescribed for treating acute Covid in patients at high risk for serious illness. The FDA granted an Emergency Use Authorization based on data showing that “Paxlovid significantly reduced the proportion of people with Covid-19 related hospitalization or death” by 88% compared to placebo.

In unvaccinated people, Paxlovid was also associated with a 26% lower risk of long Covid in a study by Ziyad Al-Aly.

The data on Paxlovid for those previously vaccinated is mixed. A smaller study from the University of California at San Francisco found no benefit in people who had been previously vaccinated.

Comments closed

Health Canada approves Pfizer-BioNTech’s updated COVID-19 vaccine

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.

Pfizer-BioNTech’s mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version that targeted the XBB.1.5 Omicron subvariant.

The approval of Comirnaty follows last week’s authorization of Moderna’s updated Spikevax mRNA vaccine and Novavax’s updated protein-based vaccine, Nuvaxovid.

Comments closed

What Repeat COVID Infections Do to Your Body, According to Science

These days, it’s tempting to compare COVID-19 with the common cold or flu. It can similarly leave you with a nasty cough, fever, sore throat—the full works of respiratory symptoms. And it’s also become a part of the societal fabric, perhaps something you’ve resigned yourself to catching at least a few times in your life (even if you haven’t already). But let’s not forget: SARS-CoV-2 (the virus responsible for COVID) is still relatively new, and researchers are actively investigating the toll of reinfection on the body. While there are still a lot of unknowns, one thing seems to be increasingly true: Getting COVID again and again is a good deal riskier than repeat hits of its seasonal counterparts.

It turns out, SARS-CoV-2 is more nefarious than these other contagious bugs, and our immune response to it, often larger and longer-lasting. COVID has a better ability to camouflage itself in the body, “and it has the keys to the kingdom in the sense that it can unlock any cell and get in,” says Esther Melamed, PhD, an assistant professor in the department of neurology at Dell Medical School, University of Texas Austin, and the research director of the Post-COVID-19 program at UT Health Austin. That’s because SARS-CoV-2 binds to ACE2 receptors, which exist in cells all over your body, from your heart to your gut to your brain. (By contrast, cold and flu viruses replicate mostly in your respiratory tract.)

Comments closed

Moderna’s updated COVID-19 vaccine is coming to Alberta, but Novavax shots are not

With the approval of Moderna’s updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans will opt to roll up their sleeves to get one.

Last week, Health Canada announced it had authorized Moderna’s new formulation, which targets the recent KP.2 subvariant, and that shipments would arrive within days.

A decision on Pfizer’s new formulation is expected in the next few weeks.

Comments closed

Health Canada approves updated Novavax COVID-19 vaccine

An updated version of Novavax’s COVID-19 vaccine has been approved by Canada’s health agency.

According to a Thursday update on the government’s vaccine portal, Health Canada will replace the older version of the protein-based vaccine, Nuvaxovid XBB.1.5. The new version will include an update to the antigen composition targeting the JN.1 variant.

“After a thorough scientific review Health Canada has approved the company’s JN.1 Variant vaccine,” the agency posted on X, formerly known as Twitter.

Comments closed

No good option: These Canadians want to be protected against COVID but are unhappy with the choice of vaccines this fall

The federal government has decided against procuring a protein-based COVID-19 vaccine for the fall immunization campaign — despite it being the only type that some immunocompromised people say they have been able to tolerate.

While the mRNA vaccines made by Pfizer and Moderna are effective at preventing severe illness, hospitalization and death, some people with autoimmune diseases say the jabs can come with a terrible trade-off.

Comments closed

Ontario: Contact councillors — save Ontario’s wastewater monitoring!

📣 Let municipal councillors know you want funding for wastewater monitoring to continue

✉️ Send letters to municipal councillors to voice your support for wastewater monitoring. Use our online tool to send emails.

Comments closed